Sansum Diabetes Research Institute (EIN 951684086) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1944

Legal Domicile

Principal Officer

Elizabeth Thompson

Phone

8056827638

Tax Period

2024-01-01 to 2024-12-31

Sansum Diabetes Research Institute, founded in 1944, is a community nonprofit in the Medical Research sector that reported $4.4M in total revenue in fiscal year 2024. Revenue fell 59% from the prior year — a significant decline worth monitoring. Expenses of $7.0M exceeded revenue, resulting in a 59% operating deficit.

Mission

Dedicated to improving the lives of people impacted by diabetes through research, education and care.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $2,056,749

Program Service Revenue $2,308,489

Investment Income $106,968

Other Revenue $-79,085

TOTAL REVENUE $4,393,121

Expense Breakdown

Grants Paid $0

Salaries & Benefits $4,805,766

Fundraising Expenses $654,996

Program Expenses $5,030,723

Other Expenses $2,164,549

TOTAL EXPENSES $6,970,315

Year-over-Year Comparison

	2024	2023	Change
Revenue	$4,393,121	$10,639,114	-0.6%
Expenses	$6,970,315	$6,651,715	+0.0%
Net Income	$-2,577,194	$3,987,399	-1.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

103

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$303,681

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Elizabeth Thompson	CEO	40.00	Officer	$272,019	$31,662	$303,681
Kristin Castorino DO	Research Physician	40.00		$269,568	$24,492	$294,060
Kristen Nelson	Director Clinical Research Operatio	40.00		$210,223	$27,631	$237,854
Kara Hornbuckle	VP Developemnt and Public Affairs	40.00		$166,532	$21,220	$187,752
Andrew Koutnik	Research Scientist	40.00		$170,414	$13,583	$183,997
Sarintha Bell	Clinical Research	40.00		$163,045	$16,498	$179,543
Mei Mei Church	Clinical Research	40.00		$158,094	$8,978	$167,072
Christian Farfan	Director Clinical	40.00		$144,318	$11,206	$155,524
Kaitelyn Kelly	SR MGR HR	40.00		$119,586	$13,221	$132,807
James Sloan	President	4.00	Officer Director	$0	$0	$0
Flint Ogle	VP/Treasurer	2.00	Officer Director	$0	$0	$0
Matthew G Rowe CIMA	Executive VP	2.00	Officer Director	$0	$0	$0
Elena F Engel	Secretary	2.00	Officer Director	$0	$0	$0
Joan Arnold	Trustee	1.00	Director	$0	$0	$0
Miguel Avila	Trustee	1.00	Director	$0	$0	$0
Daniel Berger MD	Trustee	1.00	Director	$0	$0	$0
Anthony Castillo	Trustee	1.00	Director	$0	$0	$0
Daren Dickerson	Trustee	1.00	Director	$0	$0	$0
Lindsey Duca	Trustee	1.00	Director	$0	$0	$0
Lynn Fitzgibbons MD	Trustee	1.00	Director	$0	$0	$0
Yvette Giller	Trustee	1.00	Director	$0	$0	$0
Steven Jung Esq	Trustee	1.00	Director	$0	$0	$0
Norman A Kurland	Trustee	1.00	Director	$0	$0	$0
Robert Nagy MD	Trustee	1.00	Director	$0	$0	$0
Michael J Paskin	Trustee	1.00	Director	$0	$0	$0
Wendy Thies Sell	Trustee	4.00	Director	$0	$0	$0
Mark Wilson MD	Trustee	1.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$4,393,121	$6,970,315	$26,544,993	$-2,577,194
2023	$10,639,114	$6,651,715	$27,583,956	$3,987,399
2023	$10,639,114	$6,651,715	$27,583,956	$3,987,399
2022	$8,154,412	$5,669,158	$22,174,581	$2,485,254
2021	$11,475,472	$5,271,529	$20,925,060	$6,203,943
2020	$6,046,700	$4,699,534	$17,971,488	$1,347,166
2019	$4,170,902	$5,138,512	$15,270,515	$-967,610
2019	$4,170,902	$5,138,512	$15,270,515	$-967,610
2018	$4,284,862	$4,858,981	$14,944,833	$-574,119
2018	$4,284,862	$4,858,981	$14,944,833	$-574,119
2018	$4,284,862	$4,858,981	$14,944,833	$-574,119

Sansum Diabetes Research Institute